Ausgabe 4/2014
Inhalt (12 Artikel)
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Annie Fourrier-Réglat, Denis Smith, Magali Rouyer, Jacques Bénichou, Rosine Guimbaud, Yves Bécouarn, Olivier Bernard, Pernelle Noize, Nicholas Moore, Alain Ravaud
Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study
Carmen Balaña, Miguel J. Gil, Pedro Perez, Gaspar Reynes, Oscar Gallego, Teresa Ribalta, Jaume Capellades, Sofia Gonzalez, Eugenia Verger
A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion
S. F. Mulder, M. J. Boers-Sonderen, H. F. M. van der Heijden, K. C. P. Vissers, C. J. A. Punt, C. M. L. van Herpen
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT
Marye J. Boers-Sonderen, Lioe-Fee de Geus-Oei, Ingrid M. E. Desar, Winette T. A. van der Graaf, Wim J. G. Oyen, Petronella B. Ottevanger, Carla M. L. van Herpen
Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
Minghui Zhang, Xiaosan Zhang, Shu Zhao, Yan Wang, Wenyu Di, Gangling Zhao, Maopeng Yang, Qingyuan Zhang
Immunohistochemical expression of PDGFR, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment
Nicolas Kozakowski, Caroline Hartmann, Hans Christoph Klingler, Martin Susani, Peter R. Mazal, Anke Scharrer, Andrea Haitel
Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer
Olivera Mitrović, Vladan Čokić, Dragoslava Đikić, Mirela Budeč, Sanja Vignjević, Tijana Subotički, Maja Gulan, Snežana Radović, Snežana Furtula
Insufficiency of peripheral blood as a substitute tissue for detecting EGFR mutations in lung cancer: a meta-analysis
Zhijun Li, Yongjun Zhang, Wenlong Bao, Chuming Jiang
EGFR activating mutations and their association with response to platinum-doublet chemotherapy in Brazilian non-small cell lung cancer patients
Helen N. Honma, Maurício W. Perroud Jr., Maurício S. T. Leme, Aristóteles S. Barbeiro, Bruna A. Saad, André M. Morcillo, José Vassallo, Daniel B. Costa, Lair Zambon
Significant anti-tumor effect of bevacizumab in treatment of pineal gland glioblastoma multiforme
Joshua Mansour, Braxton Fields, Samuel Macomson, Olivier Rixe